Published in PLoS One on February 12, 2014
Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry applied to virus identification. Sci Rep (2014) 0.96
Detection of Rickettsia spp in ticks by MALDI-TOF MS. PLoS Negl Trop Dis (2015) 0.90
MALDI-TOF mass spectrometry detection of pathogens in vectors: the Borrelia crocidurae/Ornithodoros sonrai paradigm. PLoS Negl Trop Dis (2014) 0.89
Leptospira species and serovars identified by MALDI-TOF mass spectrometry after database implementation. BMC Res Notes (2014) 0.86
Identification of Dermatophyte species after implementation of the in-house MALDI-TOF MS database. Int J Mol Sci (2014) 0.84
Blood-Borne Candidatus Borrelia algerica in a Patient with Prolonged Fever in Oran, Algeria. Am J Trop Med Hyg (2015) 0.82
MALDI-TOF mass spectrometry for the detection and differentiation of Entamoeba histolytica and Entamoeba dispar. PLoS One (2015) 0.79
Laboratory Diagnosis of Tick-Borne African Relapsing Fevers: Latest Developments. Front Public Health (2015) 0.76
Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass-Spectrometry (MALDI-TOF MS) Based Microbial Identifications: Challenges and Scopes for Microbial Ecologists. Front Microbiol (2016) 0.76
Identification of different respiratory viruses, after a cell culture step, by matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS). Sci Rep (2016) 0.76
Antibiotic combinations for controlling colistin-resistant Enterobacter cloacae. J Antibiot (Tokyo) (2016) 0.75
MALDI-TOF mass spectrometry as a potential tool for Trichomonas vaginalis identification. BMC Infect Dis (2016) 0.75
The anti-borreliae efficacy of phytochemicals and micronutrients: an update. Ther Adv Infect Dis (2016) 0.75
Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med (1985) 20.49
Lyme disease. N Engl J Med (1989) 14.06
Lyme borreliosis. Lancet (2011) 4.81
Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48
Climate change and infectious diseases in Europe. Lancet Infect Dis (2009) 3.86
A specific and sensitive assay for the Lyme disease spirochete Borrelia burgdorferi using the polymerase chain reaction. J Infect Dis (1989) 3.53
Genomic analysis of Borrelia japonica sp. nov. isolated from Ixodes ovatus in Japan. Microbiol Immunol (1993) 2.39
Lyme borreliosis in Europe. Euro Surveill (2011) 2.07
The expanding Lyme Borrelia complex--clinical significance of genomic species? Clin Microbiol Infect (2011) 1.55
Population genetics, taxonomy, phylogeny and evolution of Borrelia burgdorferi sensu lato. Infect Genet Evol (2011) 1.54
Emerging zoonoses and vector-borne infections affecting humans in Europe. Epidemiol Infect (2007) 1.43
Development of a clinically comprehensive database and a simple procedure for identification of molds from solid media by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2012) 1.37
Borrelia tanukii sp. nov. and Borrelia turdae sp. nov. found from ixodid ticks in Japan: rapid species identification by 16S rRNA gene-targeted PCR analysis. Microbiol Immunol (1996) 1.33
Identification of Gram-positive cocci by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry: comparison of different preparation methods and implementation of a practical algorithm for routine diagnostics. J Clin Microbiol (2013) 1.25
Clinical manifestations and diagnosis of lyme borreliosis. Curr Probl Dermatol (2009) 1.18
Comparative analysis of the genomes of intestinal spirochetes of human and animal origin. Infect Immun (1989) 1.14
Tick-borne relapsing fever and Borrelia hermsii, Los Angeles County, California, USA. Emerg Infect Dis (2009) 1.13
Lyme disease (Lyme borreliosis). Best Pract Res Clin Rheumatol (2003) 1.07
MALDI-TOF MS analysis of human and animal Brachyspira species and benefits of database extension. J Proteomics (2012) 1.00
Ability to cause erythema migrans differs between Borrelia burgdorferi sensu lato isolates. Parasit Vectors (2013) 0.93
A LightCycler TaqMan assay for detection of Borrelia burgdorferi sensu lato in clinical samples. Diagn Microbiol Infect Dis (2006) 0.92
A single-run, real-time PCR for detection and identification of Borrelia burgdorferi sensu lato species, based on the hbb gene sequence. FEMS Microbiol Lett (2006) 0.91
Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease. Clin Vaccine Immunol (2007) 0.88
Characterization of the P13 membrane protein of Borrelia burgdorferi by mass spectrometry. J Am Soc Mass Spectrom (2002) 0.86
Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borrelia burgdorferi. Ticks Tick Borne Dis (2010) 0.85
Inadequate binding of immune regulator factor H is associated with sensitivity of Borrelia lusitaniae to human complement. Infect Immun (2010) 0.84
Presence of anti-Borrelia burgdorferi antibodies and Borrelia burgdorferi sensu lato DNA in samples of subjects in an area of the Northern Italy in the period 2002-2008. Diagn Microbiol Infect Dis (2011) 0.83
Development of real time PCR to detect Toxoplasma gondii and Borrelia burgdorferi infections in postal samples. J Clin Pathol (2007) 0.80
Comparative study of the enzyme activities of Borrelia burgdorferi and other non-intestinal and intestinal spirochaetes. New Microbiol (1995) 0.80
Lyme disease in Italy: isolation of Borrelia burgdorferi from a patient. Eur J Epidemiol (1988) 0.78